Rx-to-OTC Switches
viii
Anna Maxwell, MRPharmS
Chief Executive Officer
Maxwellia, Ltd.
UK
Chapter 10
Nancy Pierro
Director, Regulatory Affairs, Rx-to-OTC Switch
Bayer Consumer Health
US
Chapter 7
Catherine Segal, RPh, MBA
Catherine Segal LLC
US
Chapter 9
Simon Shipway
Commercial Director -Switch
Bayer Consumer Health
US
Chapter 4
David Spangler, JD
Senior Vice President, Government Affairs and
Policy
Consumer Healthcare Products Association
(CHPA)
US
Chapter 1
Kate Stockman, PhD, MTOPRA
Senior Director, Global Regulatory Affairs
GSK
UK
Chapter 10
Paul A. Wardle, MA (Cantab), MMath
Founder and Principal
Beacon Associates, LLC
US
Chapter 11
RAPS would also like to recognize the work of
the following subject matter experts who volun-
teered their time to review and provide valuable
feedback to the chapter authors.
Linda Bowen, MSc, RAC, FRAPS
Head of Global Regulatory Policy and
Intelligence
Seagen Inc.
US
All Chapters
Robert Falcone, PhD, FRAPS
Senior Manager, Regulatory Affairs
Prestige Consumer Healthcare
All Chapters
Simon Gilburt, PhD
VP, Clinical Research and Medical Affairs
Cadence Health
US
Chapter 9
Barbara A. Kochanowski, PhD
Senior Vice President, Regulatory and Scientific
Affairs
Consumer Healthcare Products Association
(CHPA)
US
Chapter 5
Catherine Segal, RPh, MBA
Catherine Segal LLC
US
Chapters 2 and 3
David Spangler, JD
Senior Vice President, Government Affairs and
Policy
Consumer Healthcare Products Association
(CHPA)
US
Chapter 5
Paul A. Wardle, MA (Cantab), MMath
Founder and Principal
Beacon Associates, LLC
US
All Chapters